Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,919 | -39,261 | -28,261 | -8,522 | -3,783 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1 |
| Accounts payable and accrued liabilities | 2,291 | 329 | 3,011 | -499 | 775 |
| Other Working Capital | -4,538 | 7,284 | 8,929 | -702 | 1 |
| Other Operating Activity | -1,379 | 3,324 | -2,639 | -946 | -1,060 |
| Operating Cash Flow | $-33,544 | $-28,324 | $-18,961 | $-10,669 | $-4,067 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 977 | 668 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 3,110 |
| Common Stock Issued | 23,195 | 33,172 | 7,793 | 31,596 | 341 |
| Other Financing Activity | -519 | -668 | 0 | 0 | 9,376 |
| Financing Cash Flow | $23,653 | $33,172 | $7,793 | $31,596 | $12,827 |
| Beginning Cash Position | 23,368 | 18,520 | 29,688 | 8,761 | 0 |
| End Cash Position | 13,476 | 23,368 | 18,520 | 29,688 | 8,761 |
| Net Cash Flow | $-9,891 | $4,848 | $-11,168 | $20,928 | $8,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,544 | -28,324 | -18,961 | -10,669 | -4,067 |
| Free Cash Flow | -33,544 | -28,324 | -18,961 | -10,669 | -4,067 |